We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$390M
AUM Growth
-$27.1M
Cap. Flow
-$201M
Cap. Flow %
-51.42%
Top 10 Hldgs %
38.98%
Holding
195
New
7
Increased
42
Reduced
94
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 5.09%
3 Financials 4.96%
4 Communication Services 4.86%
5 Industrials 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
76
Blackstone
BX
$110B
$1.07M 0.27%
6,184
-10
-0.2% -$1.74K
LLY icon
77
Eli Lilly
LLY
$1.06T
$1.02M 0.26%
1,319
-8
-0.6% -$6.62K
CWI icon
78
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
$1M 0.26%
35,890
-619
-2% -$18.1K
IBDQ
79
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$1,000K 0.26%
39,918
-3,569
-8% -$89.4K
BMY icon
80
Bristol-Myers Squibb
BMY
$132B
$998K 0.26%
17,647
-524
-3% -$29.3K
DHR icon
81
Danaher
DHR
$144B
$993K 0.25%
4,328
-270
-6% -$66.4K
IBMQ icon
82
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$662M
$991K 0.25%
39,366
CFG icon
83
Citizens Financial Group
CFG
$30.6B
$978K 0.25%
22,343
+11
+0% +$486
VNQ icon
84
Vanguard Real Estate ETF
VNQ
$39B
$977K 0.25%
10,972
-208
-2% -$19.7K
VIG icon
85
Vanguard Dividend Appreciation ETF
VIG
$114B
$971K 0.25%
+4,957
New +$990K
XBI icon
86
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$968K 0.25%
10,751
-105
-1% -$10.2K
ROP icon
87
Roper Technologies
ROP
$39.8B
$960K 0.25%
1,846
-37
-2% -$20.3K
MDLZ icon
88
Mondelez International
MDLZ
$79.9B
$901K 0.23%
15,090
-412
-3% -$27.2K
JBND icon
89
JPMorgan Active Bond ETF
JBND
$8.52B
$891K 0.23%
+17,050
New +$905K
DIS icon
90
Walt Disney
DIS
$181B
$880K 0.23%
7,907
-316
-4% -$33.2K
KO icon
91
Coca-Cola
KO
$375B
$844K 0.22%
13,554
+2
+0% +$131
ITW icon
92
Illinois Tool Works
ITW
$84.5B
$817K 0.21%
3,223
-300
-9% -$79.6K
ADBE icon
93
Adobe
ADBE
$105B
$736K 0.19%
1,655
+51
+3% +$25.3K
HPQ icon
94
HP
HPQ
$27.5B
$731K 0.19%
22,413
-40
-0.2% -$1.44K
PBE icon
95
Invesco Biotechnology & Genome ETF
PBE
$292M
$723K 0.19%
10,872
-550
-5% -$37.9K
AMAT icon
96
Applied Materials
AMAT
$428B
$721K 0.18%
4,436
+1,147
+35% +$208K
TJX icon
97
TJX Companies
TJX
$178B
$692K 0.18%
5,727
-600
-9% -$71.6K
KLAC icon
98
KLA
KLAC
$259B
$691K 0.18%
10,970
-1,170
-10% -$79.1K
ABBV icon
99
AbbVie
ABBV
$435B
$690K 0.18%
3,885
-45
-1% -$8.27K
CMC icon
100
Commercial Metals
CMC
$8.31B
$688K 0.18%
13,867
+4
+0% +$226

Similar funds

Newman Dignan & Sheerar Inc's Q4 2024 Portfolio in Review

As of Q4 2024, Newman Dignan & Sheerar Inc held 195 positions worth $390M, down 6.5% from $418M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Newman Dignan & Sheerar Inc withdrew a net $201M in Q4 2024, closing 14 positions and reducing 94 holdings. Its most notable exit was Applied Finance Valuation Large Cap ETF, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Newman Dignan & Sheerar Inc opened a new position in Vanguard FTSE All-World ex-US ETF worth $2.84M.

  • Newman Dignan & Sheerar Inc's largest Q4 2024 buy was Vanguard FTSE All-World ex-US ETF: 49,391 shares worth $2.84M.
  • Newman Dignan & Sheerar Inc added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2024, an estimated $334K increase.
  • Newman Dignan & Sheerar Inc's biggest Q4 2024 reduction was Schwab US Large- Cap ETF, cutting an estimated $69.9M.
  • Newman Dignan & Sheerar Inc fully exited Applied Finance Valuation Large Cap ETF in Q4 2024, selling an estimated $22.3M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 39% of its $390M portfolio in Q4 2024.
  • Newman Dignan & Sheerar Inc opened 7 new positions and closed 14 in Q4 2024.
  • Newman Dignan & Sheerar Inc's portfolio value fell 6.5% quarter-over-quarter to $390M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q4 2024, filed 30 Jan 2025.